E7386 not checked

Eisai

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
3 active
6 in total · 2 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Colorectal Neoplasms (2 trials), Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Advanced Neoplasms, Solid Neoplasms, Gastrointestinal Tumors
Main trialPhase 1/2
“The primary objective of this study is to assess the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of E7386 in combination with other anticancer drug(s), and to determine the optimal dose of E7386 in combination with lenvatinib in endometrial carcinoma (EC) (for EC Dose Optimization Part only).”In the company’s words, NCT04008797 on ClinicalTrials.gov

Other drugs for Colorectal Neoplasms

All 392 drugs for Colorectal Neoplasms

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 1/2Active, not recruiting 31 Mar 2027 A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Phase 1Active, not recruiting 31 Mar 2027 Study of E7386 in Participants With Selected Advanced Neoplasms
Phase 1Active, not recruiting 31 Mar 2027 A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
Phase 1/2Completed 15 Oct 2024 A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
Phase 1Withdrawn 17 May 2023 A Study to Evaluate the Relative Bioavailability of E7386 Following Oral Administration of Targeted Release (TR) Tablets Compared to an E7386 Immediate Release (IR) Tablet in Healthy Adult Participants
Phase 1Completed 31 Aug 2023 A Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of Carbon-14 (14C)E7386 in Healthy Male Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow E7386

Following is part of Solo: you see every change to E7386 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in